Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Small Cell Lung Carcinoma 13Burkitt Lymphoma 9Lung Neoplasms 7Lymphoma, Non-Hodgkin 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myeloid, Acute 5Carcinoma, Non-Small-Cell Lung 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Hodgkin Disease 4Sarcoma, Ewing 3Recurrence 3Plasmablastic Lymphoma 3Multiple Myeloma 3Lymphoma, B-Cell 3Leukemia 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms, Plasma Cell 2Neoplasms 2Myelodysplastic Syndromes 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Immunoblastic Lymphadenopathy 2HIV Infections 2Ganglioneuroblastoma 2Congenital Abnormalities 2Central Nervous System Neoplasms 2

Interventions

Rituximab 2pomalidomide 1dehydroftorafur 1Watchful Waiting 1Vincristine 1Taxes 1Radiotherapy, Intensity-Modulated 1Prednisone 1Platinum 1Paclitaxel 1Nivolumab 1Gemcitabine 1Fluorouracil 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Epstein-Barr Virus Infections × Etoposide × 30 days × Clear all
NCT05389423 2026-06-01

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
25 enrolled
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡